Abilify Asimtufii Approved for Schizophrenia, Bipolar I Diso

The FDA has approved Abilify Asimtufii (aripiprazole), administered every 2 months, for schizophrenia and bipolar I disorder.

Related Keywords

Abilify Maintena , Abilify Asimtufii , Drug Administration ,